EKF Diagnostics Holdings PLC Notice of Results (3334P)
August 31 2017 - 2:01AM
UK Regulatory
TIDMEKF
RNS Number : 3334P
EKF Diagnostics Holdings PLC
31 August 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
Notice of results
Investor results presentation
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical
diagnostics business, announces that it will release its interim
results for the six months ended 30 June 2017 on Monday 11
September 2017.
Investor briefing
A briefing for all investors will take place on Monday 11
September at Côte Brasserie, 26 Ludgate Hill, London, EC4M 7DR from
4.30pm for a 4.45pm start, and will be followed by drinks and an
opportunity to network. If you would like to register for the
investor presentation, please contact Walbrook PR on 020 7933 8780
or email ekf@walbrookpr.com
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Shaun Dobson
/ Ali Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORDMGFRFGMGNZM
(END) Dow Jones Newswires
August 31, 2017 02:01 ET (06:01 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024